Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says
The companies say the treatment slowed melanoma recurrence and spread in the trial.
Comprehensive coverage of clinical trials & evidence generation news, trends, and expert analysis, providing the critical context healthcare professionals need.
The companies say the treatment slowed melanoma recurrence and spread in the trial.
The FDA announced its idea for speedier drug approvals on April 28.
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
Testing the safety and efficacy of medications will still depend on the company and the disease.
Investors were seemingly not satisfied with psilocybin trial results, but the psychedelic health community disagrees.
Oink if you love science!
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.